Quality of breast cancer care lower in U.S. territories
The quality of breast cancer care among female Medicare beneficiaries in the...Read more on AuntMinnie.comRelated Reading: Ky. Medicaid expansion improves breast cancer care Online tool offers breast cancer treatment education More women get breast screening after ACA bans copays Study: ACA led to more early-stage cancer diagnoses Women don't know about breast cancer treatment options
Genetic testing may help those at high risk take steps to prevent deadly cancers.
Studies have demonstrated increased breast cancer risk associated with postmenopausal hormone therapy, but does risk vary depending on dose, formulation, and route of delivery of estrogen-alone HT?Menopause
Conclusions: This study concluded the spatial association of cancer incidence demonstrating the high-risk regions with male predominance and role spatial risk analysis in cancer database management.
Breast cancer and EpidemiologyFor more information go tohttp://ccr.cancer.gov/training/trainee-resources/courses-workshops/tracoAir date: 10/22/2018 4:00:00 PM
Publication date: Available online 18 September 2018Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Riyazuddin Mohammed, R. Valicherla Guru, Husain Athar, Kamil Hussain Mohd, Shukla Minakshi, Katekar Roshan, P. Gupta Anand, Singh Pragati, Banerjee Dibyendu, Hajela Kanchan, R. Gayen JiaurAbstractS012-1332 is the first DNA ligase I inhibitor that demonstrated in vivo anti-breast cancer activity. The present study aimed to assess the in vivo pharmacokinetics of S012-1332 in rats and interpret them with in vitro findings. A sensitive and selective liquid chromatography-tandem mass spectrometry bioanalytical...
Survival has increased substantially for young women with breast cancer since 1975, though it has largely reached a plateau since around 2005.
CONCLUSIONS It was found that both accuracy and speed were good. We present a method that can be applied in cell morphology detection and classification in automated systems that classify by computer-aided mammogram image features. PMID: 30222727 [PubMed - in process]
Publication date: 18 September 2018Source: Cell Reports, Volume 24, Issue 12Author(s): Roy Z. Granit, Hadas Masury, Reba Condiotti, Yaakov Fixler, Yael Gabai, Tzofia Glikman, Simona Dalin, Eitan Winter, Yuval Nevo, Einat Carmon, Tamar Sella, Amir Sonnenblick, Tamar Peretz, Ulrich Lehmann, Keren Paz, Federica Piccioni, Aviv Regev, David E. Root, Ittai Ben-PorathSummaryDifferentiation events contribute to phenotypic cellular heterogeneity within tumors and influence disease progression and response to therapy. Here, we dissect mechanisms controlling intratumoral heterogeneity within triple-negative basal-like breast cancers....
Publication date: Available online 18 September 2018Source: Biosensors and BioelectronicsAuthor(s): Yuhan Yang, Yongyao Fu, Huilan Su, Li Mao, Mei ChenAbstractThe simple, rapid, sensitive, and specific detection of cancer cells plays a pivotal role in the diagnosis and prognosis of cancer. We developed a novel DNA-labeled sandwich electrochemical biosensor based on a glassy carbon electrode modified with 3D graphene and a hybrid of Au nanocages (Au NCs)/amino-functionalized multiwalled carbon nanotubes (MWCNT-NH2) for label-free and selective detection of MCF-7 breast cancer cells via differential pulse voltammetry. The la...
The MONALEESA-3 trial marks an important step forward for endocrine therapies for advanced breast cancer, argues Lidia Schapira.Medscape Oncology